In an article recently published in Nature (http: //dx.doi.org/10.1038/nature12271, 2013), a Japanese team of researchers described how they were able to produce small quantities of liver tissue that showed good vascularisation, that is, liver tissue that was quite similar to that of functioning liver tissue. This was achieved using iPS cells obtained from three human cell types.
In a comment written by Monya Baker, also published in Nature (doi: 10.10238/nature.20 13.13324), the author affirms that although they are preliminary, these results show great potential in terms of treatment for thousands of patients waiting for liver transplants.
The team produced a section of tissue that was approximately 4 mm long, and after being transplanted, mice with liver failure were able to survive for a period of time. The transplanted liver tissue even showed some hepatic activity in terms of producing liver-specific proteins and the production of metabolites that are only found in humans. But the most significant finding resulting from this study was that the liver tissue continued to grow after the transplant, due to its being well-vascularised.
According to Valerie Gouon-Evans, an expert in liver regeneration from New York’s Mount Sinai Hospital, although they are only preliminary, the results are still quite promising as the tissue was shown to connect to the host’s circulatory system, in this case the mouse, which means that it can continue to develop and achieve the hepatic function of an adult liver. Nevertheless, it has also been said that animals receiving the transplants require observation for a few months to monitor transplanted tissues for cell degeneration or the formation of tumours.
From a clinical standpoint, the development of techniques that can be used to substitute liver transplants is a significant one, for in 2011, there were 5,805 adults on waiting lists for liver transplants in the United States; furthermore, in the same year, 2,938 persons died while waiting for a transplant of this type.
The lead author of the paper, Takanori Takebe, believes that in the near future, hepatic tissue grown in the laboratory could be transferred directly into the damaged liver, enabling the organ to develop various required hepatic structures.
Generally speaking, hepatic cell experts are hopeful that this new technology could be transferred into the clinical field in the near future.
Moreover, Takanori Takebe believes this same technique can be applied to the creation of other organs such as the lungs, pancreas or kidney.